This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2004.
Company Filing History:
1 out of 834,350 Years Active: 2004
Title: Innovations in Liver Treatment by Kenneth J Simpson
Introduction
Kenneth J Simpson is a notable inventor based in Edinburgh, GB. He has made significant contributions to the field of medical science, particularly in the treatment of liver diseases. His innovative approach has led to the development of a unique patent that addresses critical health issues related to liver injury.
Latest Patents
Kenneth J Simpson holds a patent for the "Treatment of liver disease and injury with CXC chemokines." This patent reveals the surprising discovery that CXC chemokines can induce rapid hepatocyte proliferation and promote liver regeneration after injury. The invention provides a range of compositions and methods for treating liver injury, including treatments for acetaminophen overdose outside the therapeutic window for N-acetyl-cysteine treatment. Additionally, it offers solutions that limit the hepatotoxic side effects of gene therapy regimens.
Career Highlights
Throughout his career, Kenneth has focused on advancing medical treatments and improving patient outcomes. His work has been instrumental in understanding the mechanisms of liver regeneration and the potential therapeutic applications of CXC chemokines. With a patent count of 1 patent, his contributions are recognized in the medical community.
Collaborations
Kenneth has collaborated with esteemed colleagues, including Cynthia L Bone-Larson and Steven L Kunkel. These partnerships have fostered a collaborative environment that enhances research and innovation in liver treatment.
Conclusion
Kenneth J Simpson's innovative work in liver disease treatment showcases the potential of CXC chemokines in medical science. His contributions are paving the way for new therapeutic strategies that could significantly improve patient care.